Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
You must be a Standard 1 Year member to access this content.
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
You must be a Standard 1 Year member to access this content.
VISCHER and Dechert advised Forty51 Ventures on the deal. FORTY51 Ventures, a Biotech venture capital firm, closed its first fund, FORTY51 Ventures Fund I SCSp, FIAR,...
You must be a Standard 1 Year member to access this content.
VISCHER advised EBL on the deal. Swiss full-service provider Sunrise has signed an agreement to acquire the telecom business of utility firm EBL. EBL has been...
You must be a Standard 1 Year member to access this content.
VISCHER advised Mosanna Therapeutics AG on the deal. Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal counsel to Valentino. Valentino, the luxury Italian fashion house, will open a new Geneva boutique at prestigious rue du Rhône. Valentino’s CEO...
You must be a Standard 1 Year member to access this content.
VISCHER advised Novaremed AG on the deal. Novaremed AG, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics (Hong Kong) Limited, a China-based clinical stage neuroscience...
You must be a Standard 1 Year member to access this content.
Vischer, Advestra and Grandway advised Ningbo Shanshan on the deal. Niederer Kraft Frey has advised the underwriters led by Huatai Financial Holdings (Hong Kong) Limited and...
You must be a Standard 1 Year member to access this content.
VISCHER advised e-hoi AG on the deal. Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the...
You must be a Standard 1 Year member to access this content.
Vischer advised Redbiotec on the deal. Eurocine Vaccines and Redbiotec have signed a research and partnership agreement for the development of vaccine candidates against Herpes Simplex...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
You must be a Standard 1 Year member to access this content.
White & Case and Vischer advised Advanz Pharma on the deal. Advanz Pharma announced its acquisition of the ex-US business of Intercept Pharmaceuticals. ADVANZ PHARMA is a...
You must be a Standard 1 Year member to access this content.
